Abstract Uterine fibroids are common. They arise from the myometrium and occur in approximately 20–25% of women aged 35 years or more [1]. They may be found at any position…

Abstract Uterine fibroids are the most common benign neoplasms of the female reproductive tract with an estimated incidence of 25–30% at reproductive age [1]. They are detected by ultrasound in…

Abstract Fibroids have long been labelled by clinicians as a factor resulting in adverse reproductive outcomes, from conception to parturition. However, despite the widespread belief that fibroids are a detriment…

Abstract Uterine fibroids (UFs), also known as leiomyomas or myomas, are the most common benign gynaecologic neoplasm in premenopausal women worldwide and estimated to occur in 7–8 women out of…

Abstract Intramural myomas, the most common type of uterine leiomyoma, develop within the uterine wall and expand either inwards or outwards. According to the FIGO [1] leiomyoma classification system, fibroid…

Abstract Magnetic-resonance-guided focused ultrasound surgery (MRgFUS) is the only truly non-invasive procedure for the treatment of uterine fibroids. In MRgFUS, high-frequency ultrasound beams target specific tissue, in this case fibroids,…

Abstract Uterine fibroids are the most common benign tumour in premenopausal women, with a lifetime prevalence of almost 70% in Caucasian women and more than 80% in women of Afro-Caribbean…

Abstract Uterine fibroids remain the most common cause of hysterectomy. Myomectomy is performed far less than hysterectomy despite what Victor Bonney stated in 1931: ‘Since cure without deformity or loss…

Abstract One of the risks of electronic power morcellation, central to the morcellation debate, is the concern of spread of malignant uterine tissue. Uterine cancer is the most common gynaecologic…

Abstract The risk of finding an occult leiomyosarcoma (LMS) at surgery for presumed leiomyomas and subsequent outcomes for patients who have these tumours morcellated is a subject of conflict in…